Prescription attached:-
বাংলা রোগনির্ণয়: প্রায় ৮ সপ্তাহের সম্ভাব্য গর্ভাবস্থায় তলপেটে ব্যথা। জরায়ুর বাইরে গর্ভধারণ, মূত্রনালির সংক্রমণ এবং গর্ভাবস্থার প্রথম দিকের জটিলতা বাদ দেওয়া প্রয়োজন।
Clinical confidence: 0.85 — গর্ভাবস্থা ও তলপেটের ব্যথার পক্ষে প্রেসক্রিপশনে তথ্য রয়েছে। তবে আল্ট্রাসনোগ্রাফি ও Pregnancy Test-এর ফলাফল ছাড়া গর্ভের অবস্থান বা নির্দিষ্ট রোগ নিশ্চিত করা যায় না।
LIPU MED — Bilingual Prescription Review and Clinical Assessment
🟧 1. CASE IDENTIFICATION & WEBSITE CASE NUMBER — রোগীর পরিচিতি ও কেস নম্বর
Website-verified latest Obstetrics & Gynecology entry: TC(1432), Department Case No. 53, published 24 October 2026.
Proposed next case identification:
Status: Provisional — publication sequence not yet reserved. This number follows the latest Gynecology entry identified during the website review. Because a complete site-wide check of subsequently published cases could not be established, TC(1433) must not be described as officially assigned.
Patient: Mrs. N. (publication anonymised)
Age / বয়স: 20 years / ২০ বছর
Weight / ওজন: 49 kg
Prescription Date / প্রেসক্রিপশনের তারিখ: 21 October 2026
Department: Obstetrics & Gynecology / প্রসূতি ও স্ত্রীরোগ বিভাগ
Prescribing Physician: Consultant Obstetrician & Gynecologist.
Confidence: 0.98 for readable demographics; 0.65 for the proposed numbering sequence.
🟩 2. CHIEF COMPLAINTS (C/C) — প্রধান অভিযোগ
The prescription contains two entries.
| Abbreviation | English interpretation | বাংলা অর্থ | Confidence |
|---|---|---|---|
| ANC | Antenatal Care | গর্ভকালীন চিকিৎসা ও পর্যবেক্ষণ | 0.95 |
| LAP | Lower Abdominal Pain | তলপেটে ব্যথা | 0.95 |
Clinical interpretation — চিকিৎসাগত ব্যাখ্যা
ANC: The patient attended an antenatal consultation, suggesting that pregnancy was already suspected or reported.
বাংলা: রোগী গর্ভকালীন চিকিৎসা গ্রহণের জন্য এসেছেন। তবে ANC লেখা থাকলেই গর্ভাবস্থা পরীক্ষার মাধ্যমে নিশ্চিত হয়েছে, এমন সিদ্ধান্ত দেওয়া যায় না।
LAP: Pain involving the lower abdomen or pelvic region.
বাংলা: তলপেট অথবা শ্রোণি অঞ্চলে ব্যথা রয়েছে। ব্যথার প্রকৃতি, তীব্রতা, স্থায়িত্ব এবং অবস্থান প্রেসক্রিপশনে উল্লেখ নেই।
Important: Nausea, vomiting, heartburn and vaginal bleeding are not independently documented as chief complaints. Medicines may suggest these symptoms, but they cannot establish that the patient actually experienced them.
Confidence: 0.96 for the documented complaints.
🟧 3. HISTORY OF PRESENT ILLNESS (HPI) — বর্তমান অসুস্থতার ইতিহাস
Documented information / লিখিত তথ্য:
- Antenatal consultation / গর্ভকালীন পরামর্শ।
- Lower abdominal pain / তলপেটে ব্যথা।
- Last menstrual period recorded / শেষ মাসিকের তারিখ লেখা রয়েছে।
Not documented / উল্লেখ নেই:
Pain onset, duration, severity, radiation, relation to urination, fever, vaginal bleeding, vomiting frequency, dizziness and bowel symptoms.
বাংলা ব্যাখ্যা: রোগীর তলপেটে কত দিন ধরে ব্যথা, এক পাশে নাকি দুই পাশে, ব্যথার সঙ্গে রক্তপাত বা মাথা ঘোরা আছে কি না—এসব তথ্য পাওয়া যায়নি।
These omissions are clinically important because early pregnancy abdominal pain may be associated with benign conditions or potentially serious pathology.
Confidence: 0.98 regarding the missing documentation.
🟩 4. PATIENT HISTORY (I/H, O/H, D/H, M/H) — রোগীর পূর্ববর্তী ইতিহাস
| Parameter | Full meaning | বাংলা অর্থ | Prescription finding |
|---|---|---|---|
| I/H | Illness/Investigational History* | অসুস্থতা বা পূর্ববর্তী পরীক্ষার ইতিহাস | Not documented |
| O/H | Obstetric History | পূর্ববর্তী গর্ভধারণ ও প্রসবের ইতিহাস | Not documented |
| D/H | Drug History | পূর্বে ব্যবহৃত ওষুধের ইতিহাস | Not documented |
| M/H | Menstrual History | মাসিকের ইতিহাস | LMP recorded |
| P/H | Past Medical History | পূর্ববর্তী রোগের ইতিহাস | Not documented |
| S/H | Surgical History | পূর্ববর্তী অস্ত্রোপচারের ইতিহাস | Not documented |
| F/H | Family History | পারিবারিক রোগের ইতিহাস | Not documented |
*I/H is not a universally fixed abbreviation; its intended meaning depends on the clinical template.
Obstetric History — প্রসূতি ইতিহাস
Gravidity, parity, previous miscarriage, ectopic pregnancy, cesarean delivery, infertility treatment and assisted reproduction history are unavailable.
বাংলা: রোগীর আগে কতবার গর্ভধারণ হয়েছে, সন্তান আছে কি না, আগে গর্ভপাত হয়েছিল কি না কিংবা IVF-এর ইতিহাস রয়েছে কি না—কোনোটিই নিশ্চিত করা যাচ্ছে না।
Clinical significance: These details influence assessment of pregnancy complications and whether progesterone support is indicated.
Confidence: 0.99 for absence of recorded information.
🟧 5. ON EXAMINATION (O/E) & SYSTEMIC EXAMINATION (O/S/E) — শারীরিক পরীক্ষা
Readable examination findings
| Parameter | Recorded value | বাংলা ব্যাখ্যা | Interpretation |
|---|---|---|---|
| Pulse | 88 beats/min | প্রতি মিনিটে ৮৮ বার | Within usual adult resting range |
| BP | 100/60 mmHg | রক্তচাপ ১০০/৬০ | Low-normal; assess symptoms |
| Weight | 49 kg | ওজন ৪৯ কেজি | BMI cannot be calculated without height |
| Temperature | Unclear | তাপমাত্রা স্পষ্ট নয় | Cannot confirm afebrile status |
| Additional examination notes | Partly illegible | অতিরিক্ত লেখাগুলো অস্পষ্ট | No reliable interpretation possible |
Pulse confidence: 0.95. BP confidence: 0.98.
Clinical interpretation
A recorded BP of 100/60 mmHg does not independently establish shock or hemodynamic instability.
বাংলা: ১০০/৬০ রক্তচাপ থাকলেই রোগী বিপজ্জনক অবস্থায় আছেন বলা যায় না। তবে তলপেটে ব্যথার সঙ্গে মাথা ঘোরা, অজ্ঞান হওয়া, দুর্বলতা অথবা রক্তপাত থাকলে জরুরি মূল্যায়ন প্রয়োজন।
O/S/E — Other Systemic Examination
Respiratory, cardiovascular, neurological and detailed abdominal examinations are not clearly documented.
Confidence: 0.96.
🟩 6. OBSTETRIC & GYNECOLOGICAL EXAMINATION (O/G/E) — প্রসূতি ও স্ত্রীরোগ পরীক্ষা
Menstrual and pregnancy dating
LMP — Last Menstrual Period: 28 August 2026.
Assuming a reliable LMP and a regular menstrual cycle:
| Parameter | Result |
|---|---|
| LMP | 28 August 2026 |
| Gestational age on prescription date | 7 weeks + 5 days |
| Gestational age on 26 October 2026 | 8 weeks + 3 days |
| Estimated Due Date (EDD) | 4 June 2027 |
| Trimester | First trimester / প্রথম ত্রৈমাসিক |
বাংলা: শেষ মাসিকের তারিখ অনুযায়ী প্রেসক্রিপশনের দিন গর্ভকাল প্রায় ৭ সপ্তাহ ৫ দিন এবং ২৬ অক্টোবর গর্ভকাল প্রায় ৮ সপ্তাহ ৩ দিন হওয়ার কথা।
Limitation: Ultrasound may revise the gestational age and expected delivery date. These calculations do not independently confirm pregnancy.
O/G/E findings
Uterine size, cervical findings, vaginal bleeding, adnexal tenderness and cervical motion tenderness are not documented.
Confidence: 0.99 for date arithmetic; 0.70 for the clinical pregnancy estimate because LMP reliability and ultrasound findings are unknown.
🟧 7. DOCTOR’S DIAGNOSIS (Dx), PLAN & ADVICE — চিকিৎসকের রোগনির্ণয় ও পরিকল্পনা
Doctor-written diagnosis
No clearly legible, specific diagnostic label is documented.
The prescription records ANC and LAP. The medications suggest management directed toward pregnancy-associated symptoms and possible hormonal support.
বাংলা: চিকিৎসক নির্দিষ্টভাবে Threatened Miscarriage, Gastritis, UTI অথবা অন্য কোনো রোগের নাম লিখেছেন—এমন প্রমাণ পাওয়া যায়নি।
Doctor’s treatment plan
Five medicines are prescribed:
- Dexlan 30 mg capsule.
- Algin tablet.
- Actifol 5 mg tablet.
- Progest 10 mg tablet.
- Paloxi 0.5 mg tablet.
Doctor’s advice
The doctor ordered an antenatal investigation panel and indicated subsequent review. A few handwritten timing instructions are not sufficiently clear for definitive transcription.
Clinical interpretation: The overall plan appears to address antenatal assessment, abdominal discomfort, folate-related supplementation, possible progesterone support and nausea control.
Confidence: 0.90 for the treatment pattern; 0.35 for any specific undocumented diagnosis.
🟩 8. INVESTIGATIONS — চিকিৎসকের দেওয়া পরীক্ষাসমূহ
| No. | Investigation | বাংলা অর্থ | Clinical purpose |
|---|---|---|---|
| 1 | CBC | Complete Blood Count — সম্পূর্ণ রক্ত পরীক্ষা | Anaemia, infection indicators, platelets |
| 2 | RBS | Random Blood Sugar — যেকোনো সময় রক্তের গ্লুকোজ | Glucose assessment |
| 3 | GR & Rh | Blood Group and Rhesus Typing — রক্তের গ্রুপ ও আরএইচ | Maternal blood-group documentation |
| 4 | HBsAg | Hepatitis B Surface Antigen — হেপাটাইটিস বি শনাক্তকরণ | Antenatal infection screening |
| 5 | VDRL | Venereal Disease Research Laboratory Test — সিফিলিস স্ক্রিনিং | Syphilis screening; positive result requires confirmation |
| 6 | USG | Ultrasonography — আল্ট্রাসনোগ্রাফি | Pregnancy location, gestational age and viability |
| 7 | Urine R/E | Urine Routine Examination — প্রস্রাবের সাধারণ পরীক্ষা | Urinary infection or other abnormalities |
| 8 | TSH | Thyroid-Stimulating Hormone — থাইরয়েড নিয়ন্ত্রণকারী হরমোন | Thyroid-function assessment |
Important transcription note: The precise handwritten ultrasound specification is partly unclear. An additional crossed-out laboratory item cannot be reliably identified.
No investigation results are attached. Consequently, none of these tests can be described as normal, abnormal, positive or negative.
Additional assessment supported by the presentation
With early pregnancy and abdominal pain, a transvaginal ultrasound (TVUS) is particularly important to confirm the pregnancy’s location.
If pregnancy has not yet been established, perform a urine or serum pregnancy test. Serial quantitative serum β-hCG may be necessary if ultrasound is inconclusive.
Urine culture is appropriate when symptoms or screening suggest urinary infection.
Routine antenatal screening should also include HIV testing according to the applicable antenatal screening programme.
Confidence: 0.98 for clearly printed investigations; 0.93 for the need to establish pregnancy location.
🟧 9. DEFINITION, ETIOLOGY & PATHOPHYSIOLOGY — রোগের সংজ্ঞা, কারণ ও রোগতত্ত্ব
Early Pregnancy — প্রাথমিক গর্ভাবস্থা
Definition: The initial weeks of pregnancy, encompassing the first trimester through 13 weeks and 6 days.
বাংলা: গর্ভাবস্থার প্রথম ১৩ সপ্তাহ ৬ দিন পর্যন্ত সময়কে প্রথম ত্রৈমাসিক বলা হয়।
Lower Abdominal Pain — তলপেটে ব্যথা
Definition: Pain originating from structures in the lower abdomen or pelvis.
বাংলা: জরায়ু, ডিম্বাশয়, অন্ত্র, মূত্রথলি অথবা আশপাশের অঙ্গ থেকে তলপেটে ব্যথা সৃষ্টি হতে পারে।
Potential mechanisms
Pregnancy-related physiological changes: Hormonal and gastrointestinal changes may contribute to abdominal discomfort.
Ectopic Pregnancy — জরায়ুর বাইরে গর্ভধারণ: A pregnancy implants outside the uterine cavity, most commonly within a fallopian tube. Tubal distension or rupture can cause abdominal pain and internal bleeding.
Urinary Tract Infection — মূত্রনালির সংক্রমণ: Bacterial infection may cause suprapubic discomfort, dysuria and urinary frequency.
Early Pregnancy Loss — প্রাথমিক গর্ভপাত: A nonviable intrauterine pregnancy may cause pain, with or without bleeding.
বাংলা ব্যাখ্যা: শুধুমাত্র তলপেটে ব্যথা দেখে কোন রোগ হয়েছে তা নিশ্চিত করা যায় না। প্রথমে গর্ভাবস্থা জরায়ুর ভেতরে রয়েছে কি না এবং সেটি জীবিত ও স্বাভাবিকভাবে অগ্রসর হচ্ছে কি না জানতে হবে।
Confidence: 0.97 for general mechanisms; the cause in this patient remains unknown.
🟩 10. DIFFERENTIAL DIAGNOSIS (DDx) — সম্ভাব্য অন্যান্য রোগ
| Possible diagnosis | Supporting evidence | Missing evidence | Confidence |
|---|---|---|---|
| Pregnancy-related pelvic pain | ANC, LMP, LAP | Examination and USG | 0.75 |
| Ectopic pregnancy | Possible early pregnancy + LAP | TVUS and β-hCG | Not estimable; must exclude |
| Urinary tract infection | LAP is compatible | Dysuria, culture, urine findings | 0.40 |
| Gastrointestinal spasm | Algin prescribed | GI symptoms and examination | 0.40 |
| Threatened miscarriage | Early pregnancy and progestogen prescription | Vaginal bleeding, viable IUP, cervical findings | 0.25 |
| Pregnancy-associated nausea/vomiting | Paloxi prescribed | Explicit symptom history | 0.60 |
| Gastroesophageal reflux/acid dyspepsia | Dexlan prescribed | Heartburn, reflux or dyspepsia history | 0.55 |
Important diagnostic distinction
Threatened miscarriage cannot be diagnosed simply because dydrogesterone was prescribed.
Classically, threatened miscarriage involves vaginal bleeding during an ongoing pregnancy without established pregnancy loss.
Here, vaginal bleeding and ultrasound-confirmed intrauterine pregnancy are undocumented.
বাংলা: Progest দেওয়া হয়েছে বলে রোগীর গর্ভপাতের আশঙ্কা আছে—এমন নিশ্চিত সিদ্ধান্ত দেওয়া যাবে না।
Confidence: 0.98 for this diagnostic limitation.
🟧 11. MY EVIDENCE-BASED WORKING DIAGNOSIS — আমার প্রাথমিক রোগনির্ণয়
Primary Working Diagnosis
Suspected Early Pregnancy (Approximately 8 Weeks by LMP) with Lower Abdominal/Pelvic Pain — Pregnancy Location and Viability Not Yet Confirmed.
বাংলা: শেষ মাসিক অনুযায়ী প্রায় ৮ সপ্তাহের সম্ভাব্য গর্ভাবস্থার সঙ্গে তলপেটে ব্যথা; গর্ভের অবস্থান ও জীবিত থাকার বিষয়টি এখনো নিশ্চিত নয়।
Associated possible clinical problems
Possible pregnancy-associated nausea/vomiting — গর্ভাবস্থাজনিত সম্ভাব্য বমি বমি ভাব বা বমি।
Possible acid-related dyspepsia — পাকস্থলীর অতিরিক্ত অ্যাসিডজনিত সম্ভাব্য অস্বস্তি।
These are inferred from medication selection, not directly documented symptoms.
Priority exclusion
Rule Out Ectopic Pregnancy — জরায়ুর বাইরে গর্ভধারণ বাদ দিতে হবে।
Final diagnostic certainty: Moderate for an early pregnancy-related consultation, low for a specific cause of abdominal pain.
Overall confidence: 0.75.
🟩 12. DOCTOR’S Dx VS INDEPENDENT CLINICAL ASSESSMENT — চিকিৎসকের সঙ্গে রোগনির্ণয়ের তুলনা
| Parameter | Doctor’s documentation | Independent assessment |
|---|---|---|
| Early pregnancy | ANC recorded | Suspected early pregnancy |
| Lower abdominal pain | LAP recorded | Confirmed presenting complaint |
| Threatened miscarriage | Not explicitly written | Cannot establish |
| Ectopic pregnancy | Not explicitly written | Must exclude |
| Vomiting | Not explicitly recorded | Possible |
| GERD/gastritis | Not explicitly recorded | Possible |
| Pregnancy viability | Not documented | Requires ultrasound |
🟢 Areas of agreement — মিল
- ANC and LAP: Both assessments recognise antenatal consultation and lower abdominal pain.
- Pregnancy-focused investigations: The prescribed investigation panel is consistent with initial antenatal evaluation.
- Symptom-oriented medications: The medication selection suggests attempts to control associated symptoms.
🟠 Differences and diagnostic gaps — অমিল
- No confirmed doctor-written disease diagnosis: Therefore, strict disease-level concordance cannot be calculated.
- Pregnancy location: The independent assessment explicitly prioritises excluding ectopic pregnancy.
- Progestogen indication: Previous miscarriage and vaginal bleeding are not documented, so a threatened-miscarriage diagnosis cannot be inferred.
- Pregnancy medication review: Several medicines warrant reassessment for indication, safety and dosing.
Conclusion: The two assessments are broadly consistent regarding ANC and abdominal pain. A comparison of definitive diagnoses is not possible because no definitive doctor-written diagnosis is visible.
Confidence: 0.96.
🟧 13. COMPLETE MEDICATION ANALYSIS — পাঁচটি ওষুধের পৃথক বিস্তারিত বিশ্লেষণ
Medicine 1 — DEXLAN 30 mg
Prescription reading confidence: 0.95.
1. Generic Name: Dexlansoprazole — ডেক্সল্যানসোপ্রাজল।
2. Brand Name: Dexlan 30 mg EC Capsule — ডেক্সল্যান ৩০ মি.গ্রা. ক্যাপসুল।
3. MedEx Alternate Brands: Dexlazo, Dexlion, Dexnaaf, Dexnil, Aslan-D.
4. MedEx Therapeutic Class: Proton Pump Inhibitor (PPI).
5. Pharmacological Class: Gastric H⁺/K⁺-ATPase inhibitor — পাকস্থলীর অ্যাসিড উৎপাদন প্রতিরোধকারী।
6. Use/Purpose: Acid suppression and treatment of reflux-related conditions — অতিরিক্ত অ্যাসিড ও রিফ্লাক্সজনিত সমস্যার চিকিৎসা।
7. Why Prescribed in This Patient: Possibly for acid-related upper gastrointestinal symptoms. This indication is inferred, not documented.
8. Side Effects: Diarrhoea, abdominal pain, nausea and flatulence — পাতলা পায়খানা, পেটব্যথা, বমি বমি ভাব ও পেট ফাঁপা।
9. Direct MedEx Link: Dexlan 30 mg — Official MedEx
10. Unit and Strip Price: ৳10/tablet-equivalent capsule; ৳100/10-capsule strip. Also available as Dexlan 60 mg EC capsule.
11. Mechanism: Irreversible inhibition of gastric proton pumps, resulting in reduced acid secretion — পাকস্থলীর প্যারাইটাল কোষে অ্যাসিড তৈরির শেষ ধাপ বন্ধ করে।
12. Indications: GERD, erosive esophagitis and maintenance of healed erosive esophagitis — অ্যাসিড রিফ্লাক্স এবং খাদ্যনালির অ্যাসিডজনিত প্রদাহ।
13. Interactions and Contraindications: Relevant interactions include atazanavir, clopidogrel, warfarin, tacrolimus and methotrexate. Avoid in hypersensitivity.
14. Precautions: Review long-term use, significant diarrhoea, hypomagnesemia risk and other clinically relevant adverse effects.
15. Dosage and Administration: MedEx lists 30 mg once daily for symptomatic non-erosive GERD. The photographed prescription appears to indicate 1+0+1, equivalent to 60 mg/day. That exceeds the usual listed schedule for this particular indication and requires prescriber confirmation; no independent dose change should be made.
16. Pregnancy and Lactation: Human pregnancy data for dexlansoprazole are limited. The older pregnancy-letter classification appearing in some drug databases should not be interpreted as proof of fetal safety. Assess necessity and alternatives.
17. Other Combinations: No additional fixed-dose dexlansoprazole combination was verified in the reviewed MedEx listing. Available single-agent strength includes 60 mg.
Patient-specific conclusion: The prescription appears to use the drug for possible acid-related symptoms, but the indication and twice-daily schedule need confirmation.
Clinical confidence: 0.95 for drug identification; 0.55 for patient-specific indication.
Medicine 2 — ALGIN 50 mg
Prescription reading confidence: 0.95.
1. Generic Name: Tiemonium Methylsulfate — টাইমোনিয়াম মিথাইলসালফেট।
2. Brand Name: Algin 50 mg Tablet — অ্যালজিন ৫০ মি.গ্রা.।
3. MedEx Alternate Brands: Norvis, Aspasom, Deltimo, Emogin.
4. MedEx Therapeutic Class: Anticholinergics.
5. Pharmacological Class: Antimuscarinic/antispasmodic medicine — মসৃণ পেশির খিঁচুনি কমানোর ওষুধ।
6. Use/Purpose: Relief of visceral smooth-muscle spasms — পেট বা শ্রোণির অভ্যন্তরীণ অঙ্গের খিঁচুনিজনিত ব্যথা কমানো।
7. Why Prescribed in This Patient: Most likely to reduce lower abdominal spasmodic pain. However, the precise cause of pain is unknown.
8. Side Effects: Hypotension, tachycardia and possible anticholinergic effects — রক্তচাপ কমে যাওয়া, হৃদস্পন্দন বেড়ে যাওয়া এবং অ্যান্টিকোলিনার্জিক প্রতিক্রিয়া।
9. Direct MedEx Link: Algin 50 mg — Official MedEx
10. Unit and Strip Price: ৳8.50/tablet; ৳85/10-tablet strip. Other formulations include syrup 10 mg/5 mL and injection 5 mg/2 mL.
11. Mechanism: Reduces contraction of visceral smooth muscle — অভ্যন্তরীণ অঙ্গের মসৃণ পেশির সংকোচন হ্রাস করে।
12. Indications: Functional gastrointestinal, biliary, urinary and gynecological spasmodic pain.
13. Interactions and Contraindications: Avoid in patients at risk of urinary retention or angle-closure glaucoma. Review anticholinergic co-medication.
14. Precautions: Caution with cardiovascular, renal and hepatic conditions; monitor hypotensive symptoms.
15. Dosage and Administration: The handwritten schedule appears to be 1+1+1. MedEx lists an adult oral range of 2–6 tablets daily in divided doses, but this does not independently establish appropriateness in pregnancy.
16. Pregnancy and Lactation: Animal studies described by MedEx did not identify teratogenic effects; adequate human pregnancy safety evidence remains limited. Use requires a clinical benefit-risk assessment.
17. Other Combinations: No additional fixed-dose combination was verified. Syrup and injectable forms are listed.
Patient-specific conclusion: The intended purpose is probably relief of lower abdominal pain. It is symptomatic treatment and cannot exclude or treat ectopic pregnancy.
Clinical confidence: 0.97 for drug class; 0.75 for intended symptom control.
Medicine 3 — ACTIFOL 5 mg
Prescription reading confidence: 0.85.
Important medication identification: Actifol contains Folinic Acid, not ordinary Folic Acid. These formulations should not be assumed interchangeable.
1. Generic Name: Folinic Acid (Calcium Folinate) — ফলিনিক অ্যাসিড।
2. Brand Name: Actifol 5 mg Tablet — অ্যাক্টিফল ৫ মি.গ্রা.।
3. MedEx Alternate Brands: Biofol, Folimax, Folidel and Folinex (matching generic/strength where available).
4. MedEx Therapeutic Class: Supportive Care Therapy.
5. Pharmacological Class: Reduced folate derivative — ফলেটের সক্রিয় বিপাকীয় রূপ।
6. Use/Purpose: Folinate rescue following selected antifolate therapy and treatment of certain folate-related megaloblastic anaemias.
7. Why Prescribed in This Patient: The prescriber may have intended folate-related supplementation in early pregnancy. However, the exact indication is not documented, and the product is not the conventional folic-acid preparation used in routine neural-tube-defect prevention.
8. Side Effects: Hypersensitivity and gastrointestinal or mucosal adverse effects may occur; certain toxicities described in MedEx relate to oncology regimens rather than uncomplicated supplementation.
9. Direct MedEx Link: Actifol 5 mg — Official MedEx
10. Unit and Strip Price: ৳9/tablet; ৳90/10-tablet strip. Also available as Actifol 15 mg.
11. Mechanism: Supplies a reduced folate involved in nucleotide synthesis and cellular metabolism — DNA তৈরিতে প্রয়োজনীয় ফলেট-নির্ভর বিপাকীয় প্রক্রিয়ায় অংশ নেয়।
12. Indications: Methotrexate rescue and selected megaloblastic anaemias — মেথোট্রেক্সেটের বিষক্রিয়া কমানো এবং কিছু ধরনের ফলেট-সম্পর্কিত রক্তস্বল্পতা।
13. Interactions and Contraindications: Relevant interactions include antifolates, fluoropyrimidines and certain antiepileptic agents. Avoid in hypersensitivity; vitamin B12 deficiency requires appropriate evaluation.
14. Precautions: Do not substitute for standard prenatal folic acid without verifying the prescriber’s purpose.
15. Dosage and Administration: The prescription appears to indicate 0+1+0. The duration is unclear. MedEx dosing for folinic acid depends on the specific indication; oncology rescue schedules are not prenatal supplementation instructions.
16. Pregnancy and Lactation: Pregnancy use requires indication-specific benefit-risk assessment. Routine antenatal folic-acid recommendations are not automatically satisfied by prescribing this brand.
17. Other Combinations: Actifol 15 mg is available. The reviewed MedEx listing did not establish a separate fixed-dose combination.
Key pharmacological correction
Folic Acid ≠ Folinic Acid.
বাংলা: দুটি ফলেট-সম্পর্কিত ওষুধ হলেও ব্যবহার, মাত্রা ও ক্লিনিক্যাল উদ্দেশ্য এক নয়। সাধারণ গর্ভাবস্থায় WHO-এর সুপারিশ হলো প্রতিদিন 400 micrograms folic acid, সাধারণত প্রয়োজনীয় আয়রনের সঙ্গে। রোগী উচ্চঝুঁকির হলে ভিন্ন মাত্রা লাগতে পারে।
Patient-specific conclusion: Confirm whether the clinician intentionally prescribed folinic acid or intended standard prenatal folic acid.
Clinical confidence: 0.98 for MedEx generic identification; 0.50 for the physician’s intended indication.
Medicine 4 — PROGEST 10 mg
Prescription reading confidence: 0.98.
1. Generic Name: Dydrogesterone — ডাইড্রোজেস্টেরন।
2. Brand Name: Progest 10 mg Tablet — প্রোজেস্ট ১০ মি.গ্রা.।
3. MedEx Alternate Brands: Duphaston, Caryon, D-gest, Dydrogest, Rephaston and Safyron.
4. MedEx Therapeutic Class: Female Sex Hormones.
5. Pharmacological Class: Synthetic progestogen — কৃত্রিম প্রোজেস্টেরন-সদৃশ হরমোন।
6. Use/Purpose: Treatment of selected progesterone-related gynecological and reproductive conditions.
7. Why Prescribed in This Patient: Possible luteal or pregnancy support. A prior miscarriage, progesterone deficiency or threatened miscarriage cannot be confirmed from the prescription.
8. Side Effects: Headache, nausea, breast tenderness and menstrual disturbances.
9. Direct MedEx Link: Progest 10 mg — Official MedEx
10. Unit and Strip Price: ৳40/tablet; ৳600/15-tablet strip.
11. Mechanism: Activates progesterone receptors and promotes secretory changes in the endometrium — জরায়ুর অভ্যন্তরীণ আবরণে প্রোজেস্টেরন-সম্পর্কিত কার্যক্রম সৃষ্টি করে।
12. Indications: Selected miscarriage-related presentations, luteal support, certain menstrual disorders and endometriosis.
13. Interactions and Contraindications: Relevant precautions include progestogen-dependent neoplasia, significant hepatic disorders and thromboembolic history. Concurrent medicines require review.
14. Precautions: Confirm pregnancy location and viability, examine unexplained vaginal bleeding and consider relevant hepatic and thromboembolic history.
15. Dosage and Administration: The prescription appears to specify 1+0+1, or 10 mg twice daily, for approximately two months. This is a transcription of the photographed regimen, not an independent recommendation.
16. Pregnancy and Lactation: Dydrogesterone is used for selected pregnancy-related indications. It is not appropriate to infer universal benefit. MedEx advises against use during breastfeeding.
17. Other Combinations: MedEx lists Estradiol + Dydrogesterone formulations. These are hormone-replacement preparations and are not substitutes for pregnancy support.
Guideline comparison
NICE NG126 recommends vaginal micronised progesterone 400 mg twice daily for women with:
- Scan-confirmed intrauterine pregnancy;
- Vaginal bleeding; and
- At least one previous miscarriage.
If a fetal heartbeat is confirmed, treatment continues until 16 completed weeks.
This recommendation is not equivalent to prescribing oral dydrogesterone indiscriminately.
Patient-specific conclusion: Progest suggests possible pregnancy support, but the available documentation does not establish that guideline criteria for threatened-miscarriage treatment are met.
Clinical confidence: 0.98 for generic identification; 0.55 for indication; 0.95 for the guideline distinction.
Medicine 5 — PALOXI 0.5 mg
Prescription reading confidence: 0.98.
1. Generic Name: Palonosetron — প্যালোনোসেট্রন।
2. Brand Name: Paloxi 0.5 mg Tablet — পেলক্সি ০.৫ মি.গ্রা.।
3. MedEx Alternate Brands: Palevo, Palon, Palnox, Paloxiron and Palzen.
4. MedEx Therapeutic Class: Anti-emetic Drugs.
5. Pharmacological Class: Selective serotonin 5-HT₃ receptor antagonist — বমি প্রতিরোধকারী সেরোটোনিন রিসেপ্টর ব্লকার।
6. Use/Purpose: Prevention or treatment of selected nausea and vomiting presentations.
7. Why Prescribed in This Patient: Possibly pregnancy-associated nausea and vomiting. Neither symptom is independently documented.
8. Side Effects: Headache and constipation — মাথাব্যথা ও কোষ্ঠকাঠিন্য।
9. Direct MedEx Link: Paloxi 0.5 mg — Official MedEx
10. Unit and Strip Price: ৳20.06/tablet; ৳200.60/10-tablet strip. Other Paloxi formulations include a 0.5 mg dispersible tablet and injectable preparations.
11. Mechanism: Blocks serotonin-mediated stimulation of the vomiting pathway — বমির উদ্দীপনা সৃষ্টিকারী 5-HT₃ রিসেপ্টর বন্ধ করে।
12. Indications: Selected acute, delayed, chemotherapy-induced, radiotherapy-induced and postoperative nausea/vomiting.
13. Interactions and Contraindications: Avoid in hypersensitivity. Review other serotonergic medicines and clinically relevant antiemetic combinations.
14. Precautions: Confirm severity and cause of vomiting, assess hydration and review the justification for first-trimester use.
15. Dosage and Administration: The prescription appears to specify 1+0+0. MedEx lists a 0.5 mg adult oral dose for selected indications; this does not make it a standard first-line pregnancy antiemetic.
16. Pregnancy and Lactation: Pregnancy-specific evidence is more limited than for commonly recommended first-line medicines. The historical pregnancy-category designation in MedEx is insufficient to establish fetal safety.
17. Other Combinations: No additional palonosetron fixed-dose combination was verified in the reviewed MedEx brand listing.
Guideline comparison
RCOG Green-top Guideline No. 69 prioritises medicines with better-established pregnancy experience, including doxylamine/pyridoxine and selected antihistamines or phenothiazines, when pharmacological treatment is required.
Palonosetron is not a routine first-line medicine listed in that guideline.
Patient-specific conclusion: A pregnancy-focused medication review is warranted, particularly if nausea is mild or absent.
Clinical confidence: 0.98 for generic identification; 0.55 for the intended indication.
🟩 14. BANGLADESH MEDICATION COMPARISON — মেডেক্স অনুযায়ী বিকল্প ওষুধের তুলনা
These are examples of medicines available in Bangladesh, not a recommendation to prescribe them all or to replace the current regimen automatically.
| Clinical indication | Generic | Verified Bangladesh brand examples | Therapeutic role |
|---|---|---|---|
| Pregnancy-associated nausea/vomiting | Doxylamine + Pyridoxine | Dicliz Plus, Doxavit, Novea, Pregmos | First-line antiemetic option |
| Selected severe or persistent vomiting | Ondansetron | Brand selection requires product-specific verification | Second-line option after assessment |
| Confirmed acid-related reflux | Omeprazole | Cosec, Aspra, Omegut | Acid suppression |
| Routine antenatal supplementation | Iron + Folic Acid | Feofol, Ferospan, Difol TR | Iron and folate supplementation |
| Selected threatened-miscarriage cases meeting criteria | Micronised Progesterone, vaginal | Microgest 400 mg | Guideline-specific treatment |
| Selected smooth-muscle spasm | Tiemonium Methylsulfate | Algin, Norvis, Aspasom | Symptomatic antispasmodic |
Specific clinical reasons for use
1. Doxylamine + Pyridoxine: Nausea and vomiting during pregnancy / গর্ভাবস্থার বমি বমি ভাব ও বমি নিয়ন্ত্রণ। MedEx Generic and Brands
2. Omeprazole: Confirmed reflux-related symptoms when clinically required / অ্যাসিড রিফ্লাক্স কমানো। MedEx Generic and Brands
3. Iron + Folic Acid: Maternal nutritional supplementation / গর্ভাবস্থায় আয়রন ও ফলিক অ্যাসিডের প্রয়োজন পূরণ। MedEx Generic and Brands
4. Micronised Vaginal Progesterone: Selected women with bleeding, previous miscarriage and confirmed intrauterine pregnancy / নির্দিষ্ট শর্ত পূরণকারী রোগীর গর্ভধারণে প্রোজেস্টেরন সাপোর্ট। MedEx Microgest Listing
Important: Drug availability and MedEx indications do not replace maternal-fetal safety assessment or guideline-based prescribing.
Confidence: 0.94 for verified medicine availability; clinical suitability must be determined individually.
🟧 15. EDUCATIONAL PRESCRIPTION DEMONSTRATION — নমুনা ক্লিনিক্যাল প্রেসক্রিপশন
CLINICAL ASSESSMENT NOTE — EDUCATIONAL DEMONSTRATION ONLY
Patient: Mrs. N.
Age: 20 years
Weight: 49 kg
Department: Obstetrics & Gynecology.
C/C:
ANC — Antenatal consultation.
LAP — Lower abdominal pain.
M/H:
LMP: 28/08/2026.
GA on 21/10/2026: 7 weeks 5 days by LMP.
O/E:
Pulse: 88/min.
BP: 100/60 mmHg.
Other findings: Insufficiently documented.
Clinical Dx Note
Provisional Dx: Suspected Early Pregnancy (~7+5 Weeks by LMP on 21/10/2026) with Lower Abdominal Pain; Pregnancy Location/Viability Unconfirmed. R/O Ectopic Pregnancy and UTI.
বাংলা: প্রায় ৭ সপ্তাহ ৫ দিনের সম্ভাব্য গর্ভাবস্থায় তলপেটে ব্যথা। গর্ভের অবস্থান নিশ্চিত নয়; জরায়ুর বাইরে গর্ভধারণ ও মূত্রনালির সংক্রমণ বাদ দিতে হবে।
Recommended assessment:
- Confirm pregnancy status.
- TVUS to confirm intrauterine location and assess viability.
- Quantitative serum β-hCG if required by ultrasound findings.
- CBC, urine R/E and culture when indicated.
- Review blood group/Rh, antenatal infection screening and TSH as appropriate.
- Review all five previously prescribed medicines against the confirmed indication.
Previously documented medicines: Dexlan, Algin, Actifol, Progest and Paloxi.
Medication status: Requires reconciliation and prescriber review. This demonstration does not issue replacement doses or authorise continuation, discontinuation or substitution.
Follow-up: Obstetric review after investigations, with earlier emergency assessment for red-flag symptoms.
Confidence: 0.92 that this is an appropriate provisional diagnostic documentation format.
🟩 16. OVERVIEW, ACTIONABLE PLAN & REFERRAL — সারাংশ, করণীয় ও রেফারেল
Overview / সারাংশ
A 20-year-old patient attended an antenatal consultation on 21 October 2026 with lower abdominal pain. The LMP suggests approximately 7 weeks and 5 days of pregnancy at that visit.
Pregnancy location, viability and the exact cause of pain have not been established.
বাংলা: ২০ বছর বয়সী রোগীর তলপেটে ব্যথা রয়েছে। মাসিকের তারিখ অনুযায়ী গর্ভাবস্থার প্রথম দিকে থাকার সম্ভাবনা আছে। তবে আল্ট্রাসনোগ্রাফি ছাড়া গর্ভের অবস্থান ও অবস্থা নিশ্চিত করা যাবে না।
Actionable Plan / করণীয়
Priority 1 — Establish pregnancy location.
If pain persists, arrange prompt obstetric assessment and appropriate ultrasound. Do not delay evaluation solely because antispasmodic medication has been prescribed.
Priority 2 — Emergency referral if red flags occur.
Severe or worsening abdominal pain, unilateral pelvic pain, shoulder-tip pain, syncope, marked dizziness or substantial vaginal bleeding require emergency assessment.
Priority 3 — Review the prescription.
Confirm the indication and dosing of Dexlan, the pregnancy safety rationale for Algin and Paloxi, the intended folate preparation (Actifol versus folic acid), and the indication for Progest.
Priority 4 — Complete antenatal screening.
Review CBC, group/Rh, infection screening, glucose and thyroid testing according to the clinical presentation and local antenatal protocols.
Priority 5 — Document obstetric history.
Record gravida, para, abortions, previous ectopic pregnancy, bleeding history and assisted-conception history.
Referral Department
Primary referral: Obstetrics & Gynecology — Early Pregnancy Assessment Service / প্রসূতি ও স্ত্রীরোগ বিভাগের প্রাথমিক গর্ভাবস্থা মূল্যায়ন সেবা।
Emergency referral: Gynecology Emergency or an emergency department with obstetric and ultrasound support when clinically indicated.
Final Clinical Impression
Suspected First-Trimester Pregnancy with Lower Abdominal Pain — Etiology Undetermined; Exclude Ectopic Pregnancy Before Attributing Pain to Benign Causes.
বাংলা চূড়ান্ত প্রাথমিক মূল্যায়ন: গর্ভাবস্থার প্রথম ত্রৈমাসিকে তলপেটে ব্যথা; ব্যথার কারণ এখনো নির্ধারিত নয়। সাধারণ ব্যথা ধরে নেওয়ার আগে জরায়ুর বাইরে গর্ভধারণ বাদ দিতে হবে।
Overall diagnostic confidence: 0.75.
Confidence in the need for timely assessment: 0.96.
🟧 17. EVIDENCE-BASED REFERENCES — চিকিৎসাবিজ্ঞানের নির্ভরযোগ্য তথ্যসূত্র
Medical Textbooks — চিকিৎসাবিজ্ঞানের পাঠ্যবই
1. Williams Obstetrics. 26th edition. McGraw Hill; 2022. Relevant topics: prenatal care, early pregnancy assessment, miscarriage and ectopic pregnancy.
2. Berek & Novak’s Gynecology. 16th edition. Wolters Kluwer; 2020. Relevant topics: reproductive endocrinology and early pregnancy complications.
3. Katzung’s Basic & Clinical Pharmacology. 16th edition. McGraw Hill; 2024. Relevant pharmacological topics: gastrointestinal medicines, antiemetics and steroid hormones.
4. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th edition. McGraw Hill; 2023. Relevant topics: pharmacodynamics of proton-pump inhibitors, antiemetics and hormone-related treatment.
International Guidelines — আন্তর্জাতিক চিকিৎসা নির্দেশিকা
5. NICE NG126: Ectopic Pregnancy and Miscarriage: Diagnosis and Initial Management. Published 2019; updated June 2026. Official NICE Guideline
6. NICE NG201: Antenatal Care. Published 2021. Official NICE Antenatal Care Guidance
7. WHO: Daily Iron and Folic Acid Supplementation During Pregnancy. Updated 2024. WHO Recommendation
8. RCOG: Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum, Green-top Guideline No. 69. Updated 2024. RCOG Guideline
Peer-Reviewed Journals with DOI — গবেষণাপত্র
9. Coomarasamy A, et al. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy. New England Journal of Medicine. 2019;380:1815–1824.
DOI: 10.1056/NEJMoa1813730.
10. Nelson-Piercy C, et al. The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum. BJOG. 2024.
DOI: 10.1111/1471-0528.17739.
Final Author Information
Author: Md.Rafiqul Islam Lipu
Publication: LIPU MED — Clinical Prescription Review
Date: Monday, 26 October 2026
Time: 5:46 PM (Bangladesh Standard Time, UTC+06:00)
Clinical publication note: This is a retrospective analysis of a photographed prescription, not an examination of the patient or an independently authorised prescription. All inferences are explicitly separated from documented findings. A definitive diagnosis requires appropriate clinical assessment and investigation results.
🔎 Verification notes
The website’s Obstetrics & Gynecology archive displays TC(1432), Case No. 53, published on 24 October 2026. The proposed TC(1433), Case No. 54 is therefore a sequential draft, not a verified newly published case number.
The five drug identifications were checked against MedEx, including the clinically important distinction between Actifol (folinic acid) and routine folic acid supplementation. Their listed unit and strip prices are reference prices and may change.
Most important clinical decision: Because lower abdominal pain is documented during suspected early pregnancy, confirming pregnancy location takes priority over assigning a diagnosis solely from the prescribed medicines. NICE recommends specialist assessment and ultrasound for relevant early-pregnancy pain presentations.